WO2008099608A1 - Procédé de diagnostic d'une maladie intestinale inflammatoire - Google Patents

Procédé de diagnostic d'une maladie intestinale inflammatoire Download PDF

Info

Publication number
WO2008099608A1
WO2008099608A1 PCT/JP2008/000222 JP2008000222W WO2008099608A1 WO 2008099608 A1 WO2008099608 A1 WO 2008099608A1 JP 2008000222 W JP2008000222 W JP 2008000222W WO 2008099608 A1 WO2008099608 A1 WO 2008099608A1
Authority
WO
WIPO (PCT)
Prior art keywords
inflammatory bowel
bowel disease
diagnosis
activity
disclosed
Prior art date
Application number
PCT/JP2008/000222
Other languages
English (en)
Japanese (ja)
Inventor
Shingo Kato
Koji Yakabi
Yukio Ito
Mina Sagara
Original Assignee
Saitama Medical University
Perseus Proteomics Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saitama Medical University, Perseus Proteomics Inc. filed Critical Saitama Medical University
Priority to JP2008558008A priority Critical patent/JP5280214B2/ja
Publication of WO2008099608A1 publication Critical patent/WO2008099608A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne un procédé pour le diagnostic de la présence d'une maladie intestinale inflammatoire et/ou l'activité d'une maladie intestinale inflammatoire. L'invention concerne de façon spécifique un procédé pour la détermination de la présence d'une maladie intestinale inflammatoire et/ou l'activité d'une maladie intestinale inflammatoire, qui est caractérisée par la mesure du niveau de PTX3 dans un échantillon.
PCT/JP2008/000222 2007-02-15 2008-02-14 Procédé de diagnostic d'une maladie intestinale inflammatoire WO2008099608A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008558008A JP5280214B2 (ja) 2007-02-15 2008-02-14 炎症性腸疾患の診断方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007034233 2007-02-15
JP2007-034233 2007-02-15

Publications (1)

Publication Number Publication Date
WO2008099608A1 true WO2008099608A1 (fr) 2008-08-21

Family

ID=39689855

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/000222 WO2008099608A1 (fr) 2007-02-15 2008-02-14 Procédé de diagnostic d'une maladie intestinale inflammatoire

Country Status (2)

Country Link
JP (1) JP5280214B2 (fr)
WO (1) WO2008099608A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011254810A (ja) * 2010-05-12 2011-12-22 En Otsuka Pharmaceutical Co Ltd クローン病の活動性の分類
JP2012053034A (ja) * 2010-08-06 2012-03-15 Perseus Proteomics Inc 炎症状態の検出方法
WO2019056991A1 (fr) * 2017-09-19 2019-03-28 臻崴生物科技有限公司 Anticorps monoclonal ou fragment de liaison à l'antigène de celui-ci, et son utilisation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005106494A2 (fr) * 2004-04-29 2005-11-10 Farma Development S.R.L. Anticorps monoclonaux, hybridomes, procede ameliore pour la determination de la proteine ptx3 et trousse pour ladite determination

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005106494A2 (fr) * 2004-04-29 2005-11-10 Farma Development S.R.L. Anticorps monoclonaux, hybridomes, procede ameliore pour la determination de la proteine ptx3 et trousse pour ladite determination

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OKUTANI D.: "Atarashii Mediator Pentraxin3 no Ensho Hanno ni Okeru Yakuwari", JPN. J. IMMUNOL., vol. 29, no. 3, 2006, pages 107 - 113, XP003020687 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011254810A (ja) * 2010-05-12 2011-12-22 En Otsuka Pharmaceutical Co Ltd クローン病の活動性の分類
JP2012053034A (ja) * 2010-08-06 2012-03-15 Perseus Proteomics Inc 炎症状態の検出方法
WO2019056991A1 (fr) * 2017-09-19 2019-03-28 臻崴生物科技有限公司 Anticorps monoclonal ou fragment de liaison à l'antigène de celui-ci, et son utilisation

Also Published As

Publication number Publication date
JP5280214B2 (ja) 2013-09-04
JPWO2008099608A1 (ja) 2010-05-27

Similar Documents

Publication Publication Date Title
WO2010053587A3 (fr) Procédés de surveillance de maladies par analyse de séquence
WO2010025393A3 (fr) Marqueurs biologiques protéiques et méthodes pour diagnostiquer la maladie de kawasaki
WO2011072177A3 (fr) Dosage de biomarqueurs pour le diagnostic et le classement des maladies cardiovasculaires
WO2007056523A3 (fr) Procedes de diagnostic et de surveillance de la progression d'un cancer
WO2008008284A3 (fr) Biomarqueurs du cancer et méthodes d'utilisation
WO2007127749A3 (fr) Prédiction de la mortalité et détection d'une maladie grave
WO2005114190A3 (fr) Procedes pour identifier des marqueurs biologiques
IL185477A0 (en) Diagnostic methods and systems based on urine analysis
EP2024745A4 (fr) Dosages biologiques pour le diagnostic et l'evaluation d'options de traitement de la maladie de fabry
WO2009085234A3 (fr) Utilisation d'un micro-arn à titre de marqueur biologique d'une activité médicamenteuse immunomodulatoire
WO2008135862A3 (fr) Dispositifs et procédés pour détecter des analysats
WO2009085356A8 (fr) Procédés d'utilisation et de construction de plate-formes de nanocapteurs
WO2008122670A3 (fr) Gène tnfrsf10b de susceptibilité au diabète chez l'homme
DE602007011566D1 (en) Ankheit
WO2008027098A3 (fr) Biocapteur pour la mesure d'espèces dans un fluide corporel
WO2011021041A3 (fr) Dosage pronostique de détermination de la survie
WO2010045490A3 (fr) Mappage sur hyperespace multidimensionnel de biomarqueur humain pour des troubles dépressifs
WO2009114756A3 (fr) Biomarqueurs pour maladie intestinale inflammatoire et syndrome du côlon irritable
WO2007030949A3 (fr) Procedes de diagnostic de cancer des ovaires et necessaires a cet effet
EP2075341A4 (fr) Procédé d'étude, de détermination ou d'évaluation par l'analyse de l'expression d'un gène
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010046648A3 (fr) Essai diagnostique pour streptococcus equi
WO2010090834A3 (fr) La nétrine-1 comme marqueur biologique de lésion et de maladie
WO2008155891A1 (fr) Nouveau marqueur d'une maladie artériosclérotique
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08710376

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2008558008

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08710376

Country of ref document: EP

Kind code of ref document: A1